Senility. Senility
Conditions
Interventions
Intervention 1: Intervention group: A-tDCS will apply via two saline soaked sponge electrodes(7cm×5cm). An iontophoresis device(ActivaDose® II Unit, ActivaTek, Inc. Salt Lake City, UT) will use as a c
we will use 10-20 EEG system. In the anodal tDCS group the current intensity will be 1 mA conduct for 20 minutes in five consecutive days. The interval between each session will be 24 hours and the se
10 seconds ramp up, 10 seconds the device will be on and 10 seconds for ramp down. Participants will be blind to the type of stimulation and the tDCS device will keep out of their range of vision. Ele
Treatment - Devices
Treatment - Drugs
Intervention group: A-tDCS will apply via two saline soaked sponge electrodes(7cm×5cm). An iontophoresis device(ActivaDose® II Unit, ActivaTek, Inc. Salt Lake City, UT) will use as a constant direct c
Sham-control group: In sham condition up to 30 seconds the current will be conduct
Sponsors
University of Social Welfare and Rehabilitation Aging research center
Eligibility
Sex/Gender
All
Age
60 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 60= years old; MMSE score> 23; Participants lived independently, and were able to complete their routine activities of daily life without assistance and Exclusion criteria: injury or any diseases related to brain such as seizure, stroke, TBI.; severe musculoskeletal dysfunctions; severe visual and auditory dysfunction; balance impairment and positional vertigo; acute dermatitis; presence of implanted device such as pace-maker or metal in the skull.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional performance. Timepoint: pretest, immediately after in 5th session, 30 minutes after in 5th session and one week following end of treatment. Method of measurement: 1. Purdue pegboard test 2.Timed up and go test 3. 30 second chair raise test 4. Modified figure of eight 5. Box stepping. | — |
Secondary
| Measure | Time frame |
|---|---|
| Itching. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Tingling. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Burning sensation. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Headache. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Warmness. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Discomfort. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Trouble concentrating. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Acute mood change. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale.;Fatigue. Timepoint: every session; during and after stimulation. Method of measurement: Side effects of tDCS questionnaire; Numerical analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohamad Rostami
University of Social Welfare and Rehabilitation, physiotherapy devision
Outcome results
None listed